Here, we demonstrated that siBeclin1 can be used to increase the efficacy of antiretrovirals in decreasing viral infections and that siBeclin1 can also be used to reduce the secretion of inflammatory cytokines such as, MCP-1, IL-6, and RANTES in glial cells (Figure 1). This evidence concerns the gene CCL5 and viral infectious disease.